Nevirapine |
Nevirapine Products |
| Nevirapine results quickly put into practice.: An article from: Network Kerry L. Wright Family Health International The Gale Group Family Health International |
Sale Price: $5.95
|
| Nevirapine can lead to hepatotoxicity in women: medwatch alert.(Rx): An article from: Family Practice News Steve Perlstein International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Nevirapine resistance tied to timing of treatment.(Infectious Diseases): An article from: Family Practice News Sherry Boschert International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Treatment of nevirapine-associated DRESS syndrome with intravenous immune globulin (IVIG).(CASE REPORTS): An article from: Journal of Drugs in Dermatology Katherine S. Fields, Marta J. Petersen, Elizabeth Chiao, Payam Tristani-Firouzi Journal of Drugs in Dermatology, Inc. Journal of Drugs in Dermatology, Inc. |
Sale Price: $5.95
|
| Resistance after single-dose nevirapine is time related.(Obstetrics): An article from: OB GYN News Sherry Boschert International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Nevirapine can lead to hepatotoxicity in women.(Medwatch Alert): An article from: Internal Medicine News Steve Perlstein International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Efavirenz vs. nevirapine for HIV trial inconclusive: head-to-head trial a draw.(Dermatoligic Theraphy): An article from: Skin & Allergy News Diana Mahoney International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Nevirapine court battle moves favourably for HIV positive women.: An article from: Sister Namibia Sister Namibia The Gale Group Sister Namibia |
Sale Price: $5.95
|
| Efavirenz and nevirapine: which baffles HIV best? (Head-to-Head Trial).: An article from: Internal Medicine News Diana Mahoney International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Trial of efavirenz vs. nevirapine for HIV ends in a draw. (Multicenter, International Study).: An article from: Family Practice News Diana Mahoney International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|

Not Signed In - 


